Abstract
The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 recommends a comprehensive multidimensional assessment for patients with chronic obstructive pulmonary disease (COPD) and stresses the need for evaluation of their health status and quality of life (QOL). COPD assessment test (CAT), clinical COPD questionnaire (CCQ) and St. George Respiratory questionnaire (SGRQ) are recommended by GOLD for such assessments. However, their correlation with spirometry in the Indian population is not known. Other similar questionnaires like COPD and sleep impact scale (CASIS), functional performance inventory-short form (FPI-SF) and COPD and asthma fatigue scale (CAFS) though used internationally as a research tool, are still in the offspring stage and have never been used in India. A cross-sectional study was hence conducted in the Department of Pulmonary Medicine, Government Medical College, Patiala, Punjab, India on 100 COPD patients. Patients were assessed for health status and QOL by CAT, CCQ, SGRQ, CASIS, FPI-SF and CAFS. The relationship between these questionnaires and airflow limitation was investigated. The majority of the patients were males (n=97) and >50 years of age (n=83), illiterate (n=72), had moderate/severe COPD and belonged to group B (n=66). The mean value of forced expiratory volume in one second (%FeV1) decreased with a deterioration in CAT and CCQ score grouping (p<0.001). Patients with poorer CAT and CCQ scores belonged to higher GOLD grades (kappa=0.33, p<0.001). The correlation of health-related quality of life (HRQL) questionnaires amongst each other, with FEV1 predicted and with GOLD grade was strong to very strong in most of the comparisons (p<0.01 in the majority). On comparison of GOLD grade with mean scores of HRQL questionnaires, it was seen that with the increase in GOLD grading from 1 to 4, the mean value of CAT, CCQ, SGRQ, CASIS, FPI SF and CAFS also deteriorated (p<0.001, p<0.001, p<0.001, p<0.005, p<0.001 and p<0.001, respectively). Various easy-to-use HRQL scores should be routinely used in outpatient departments for a comprehensive assessment of COPD patients. These questionnaires, in combination with clinical features, can help in providing a rough estimate of the severity of the disease at places where lung function assessments are not readily available.
Subject
Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine
Reference28 articles.
1. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease, 2023 Report. Accessed: 2023 Apr 05. Available from: https://goldcopd.org/wp-content/uploads/2023/03/GOLD-2023-ver-1.3-17Feb2023_WMV.pdf
2. Jones PW, Harding G, Berry P, et al. Development and first validation of the COPD Assessment Test. Eur Resp J 2009;34:648-54.
3. van der Molen T, Willemse BW, Schokker S, et al. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:1-0.
4. Guyatt GH, Berman LB, Townsend M, et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987;42:773-8.
5. Kharbanda S, Anand R. Health-related quality of life in patients with chronic obstructive pulmonary disease: A hospital-based study. Indian J Med Res 2021;153:459-64.